Colgate-Palmolive (NYSE: CL ) is finally on sale. The company's shares have fallen 15% since hitting a high back in May. Is this the dip that sidelined investors have been waiting for?
In the video below, Fool contributor Demitrios Kalogeropoulos argues that, while Colgate can still seem expensive compared to consumer goods rivals Procter & Gamble (NYSE: PG ) and Clorox (NYSE: CLX ) , it brings a few qualities to the table that make it worth that premium. For example, the company is boosting its already dominant market-share position in key products, and its heavy exposure to international business is a source of profit growth. Demitrios sees this recent sell-off as a chance for long-term investors to get into a high-quality dividend stock at a reasonable price.
The price of becoming the world's greatest investor is that Warren Buffett can no longer make many of types of investments that made him rich in the first place. Find out about one such opportunity in "The Stock Buffett Wishes He Could Buy." The free report details a sector of the economy Buffett's heavily invested in right now and exactly why he can't buy one attractive company in that sector. Click here to keep reading.